Clean Science and Technology Limited
Clean Science and Technology Limited, together with its subsidiaries, manufactures fine and specialty chemicals in India, China, the Americas, Europe, and internationally. It operates through Performance Chemicals, FMCG Chemicals, and Pharmaceutical & Agro Intermediates segments. The company offers performance chemicals, including monomethyl ether of hydroquinone, butylated hydroxy anisole, terti… Read more
Clean Science and Technology Limited (CLEAN) - Net Assets
Latest net assets as of September 2025: ₹15.00 Billion INR
Based on the latest financial reports, Clean Science and Technology Limited (CLEAN) has net assets worth ₹15.00 Billion INR as of September 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (₹16.84 Billion) and total liabilities (₹1.84 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | ₹15.00 Billion |
| % of Total Assets | 89.05% |
| Annual Growth Rate | 33.45% |
| 5-Year Change | 162.46% |
| 10-Year Change | N/A |
| Growth Volatility | 13.69 |
Clean Science and Technology Limited - Net Assets Trend (2018–2025)
This chart illustrates how Clean Science and Technology Limited's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Clean Science and Technology Limited (2018–2025)
The table below shows the annual net assets of Clean Science and Technology Limited from 2018 to 2025.
| Year | Net Assets | Change |
|---|---|---|
| 2025-03-31 | ₹14.16 Billion | +17.72% |
| 2024-03-31 | ₹12.03 Billion | +19.13% |
| 2023-03-31 | ₹10.10 Billion | +31.43% |
| 2022-03-31 | ₹7.68 Billion | +42.39% |
| 2021-03-31 | ₹5.40 Billion | +57.75% |
| 2020-03-31 | ₹3.42 Billion | +25.74% |
| 2019-03-31 | ₹2.72 Billion | +44.82% |
| 2018-03-31 | ₹1.88 Billion | -- |
Equity Component Analysis
This analysis shows how different components contribute to Clean Science and Technology Limited's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 706.9% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (March 2025)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | ₹13.95 Billion | 98.51% |
| Common Stock | ₹106.27 Million | 0.75% |
| Other Comprehensive Income | ₹64.63 Million | 0.46% |
| Other Components | ₹39.78 Million | 0.28% |
| Total Equity | ₹14.16 Billion | 100.00% |
Clean Science and Technology Limited Competitors by Market Cap
The table below lists competitors of Clean Science and Technology Limited ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Guangdong Enpack Packaging Co Ltd
SHE:002846
|
$375.08 Million |
|
EMX Royalty Corp
NYSE MKT:EMX
|
$375.28 Million |
|
Longyan Zhuoyue New Energy Co Ltd
SHG:688196
|
$375.32 Million |
|
Sabre Corpo
NASDAQ:SABR
|
$375.34 Million |
|
BLUE LABEL
MU:5TP
|
$374.98 Million |
|
Suzhou HYC Technology Co Ltd
SHG:688001
|
$374.79 Million |
|
Aditya Birla Fashion and Retail Limited
NSE:ABFRL
|
$374.74 Million |
|
Synmosa Biopharma
TWO:4114
|
$374.66 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Clean Science and Technology Limited's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 12,031,650,000 to 14,164,160,000, a change of 2,132,510,000 (17.7%).
- Net income of 2,644,050,000 contributed positively to equity growth.
- Dividend payments of 531,320,000 reduced retained earnings.
- New share issuances of 9,410,000 increased equity.
- Other comprehensive income decreased equity by 2,020,001.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | ₹2.64 Billion | +18.67% |
| Dividends Paid | ₹531.32 Million | -3.75% |
| Share Issuances | ₹9.41 Million | +0.07% |
| Other Comprehensive Income | ₹-2.02 Million | -0.01% |
| Other Changes | ₹12.39 Million | +0.09% |
| Total Change | ₹- | 17.72% |
Book Value vs Market Value Analysis
This analysis compares Clean Science and Technology Limited's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 5.17x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has decreased from 38.99x to 5.17x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2018-03-31 | ₹17.69 | ₹689.55 | x |
| 2019-03-31 | ₹25.61 | ₹689.55 | x |
| 2020-03-31 | ₹32.21 | ₹689.55 | x |
| 2021-03-31 | ₹50.81 | ₹689.55 | x |
| 2022-03-31 | ₹72.32 | ₹689.55 | x |
| 2023-03-31 | ₹95.05 | ₹689.55 | x |
| 2024-03-31 | ₹113.22 | ₹689.55 | x |
| 2025-03-31 | ₹133.28 | ₹689.55 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Clean Science and Technology Limited utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 18.67%
- The company demonstrates strong efficiency in generating profits from shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 27.35%
- • Asset Turnover: 0.60x
- • Equity Multiplier: 1.14x
- Recent ROE (18.67%) is below the historical average (29.68%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2018 | 26.03% | 20.28% | 1.02x | 1.26x | ₹301.12 Million |
| 2019 | 35.90% | 24.83% | 1.20x | 1.20x | ₹704.52 Million |
| 2020 | 40.82% | 33.30% | 0.98x | 1.26x | ₹1.05 Billion |
| 2021 | 36.76% | 38.71% | 0.78x | 1.22x | ₹1.44 Billion |
| 2022 | 29.73% | 33.36% | 0.74x | 1.20x | ₹1.52 Billion |
| 2023 | 29.23% | 31.54% | 0.81x | 1.14x | ₹1.94 Billion |
| 2024 | 20.28% | 30.83% | 0.57x | 1.16x | ₹1.24 Billion |
| 2025 | 18.67% | 27.35% | 0.60x | 1.14x | ₹1.23 Billion |
Industry Comparison
This section compares Clean Science and Technology Limited's net assets metrics with peer companies in the Specialty Chemicals industry.
Industry Context
- Industry: Specialty Chemicals
- Average net assets among peers: $2,571,777,102
- Average return on equity (ROE) among peers: 15.48%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Clean Science and Technology Limited (CLEAN) | ₹15.00 Billion | 26.03% | 0.12x | $375.05 Million |
| Aarti Industries Limited (AARTIIND) | $8.75 Billion | 18.56% | 2.05x | $1.01 Billion |
| Aarti Surfactants Limited (AARTISURF) | $2.18 Billion | 9.78% | 0.94x | $15.14 Million |
| ABM International Limited (ABMINTLLTD) | $214.51 Million | 3.09% | 0.89x | $294.24K |
| ACUTAAS CHEMICALS LTD (ACUTAAS) | $5.94 Billion | 14.02% | 0.29x | $247.08K |
| Advanced Enzyme Technologies Limited (ADVENZYMES) | $984.09 Million | 34.30% | 2.55x | $95.16 Million |
| Agarwal Industrial Corporation Limited (AGARIND) | $739.40 Million | 9.29% | 0.98x | $26.89 Million |
| Alkali Metals Limited (ALKALI) | $513.80 Million | 2.54% | 0.73x | $1.88 Million |
| Alkyl Amines Chemicals Limited (ALKYLAMINE) | $3.79 Billion | 22.71% | 1.01x | $204.91 Million |
| Ami Organics Limited (AMIORG) | $107.73 Million | 26.58% | 2.59x | $704.27 Million |
| Anupam Rasayan India Limited (ANURAS) | $2.50 Billion | 13.94% | 1.53x | $318.75 Million |